WhitTier Trust Company’s 10x Genomics TXG Stock Holding History

WhitTier Trust Company’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-323	Closed	-$11.8K	–	1225
2022 Q4	$11.8K	Buy	323 +256	+382%	+$8.37K	﹤0.01%	923
2022 Q3	$2K	Sell	67 -128	-66%	-$4.88K	﹤0.01%	1041
2022 Q2	$9K	Buy	195 +100	+105%	+$5.19K	﹤0.01%	940
2022 Q1	$7K	Buy	95 +24	+34%	+$2.1K	﹤0.01%	979
2021 Q4	$11K	Buy	+71	New	+$10.9K	﹤0.01%	898

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

WhitTier Trust Company's TXG Position: Q1 2023 in Review

WhitTier Trust Company sold out of 10x Genomics (TXG) in Q1 2023, closing a stake of 323 shares — an estimated $11.8K sold.

WhitTier Trust Company first reported a position in TXG in Q4 2021 and held it in 5 quarters. The position peaked at $11.8K in Q4 2022. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

WhitTier Trust Company reported no remaining 10x Genomics position as of Q1 2023 after selling out during the quarter.
WhitTier Trust Company sold 323 10x Genomics shares in Q1 2023, an estimated $11.8K.
WhitTier Trust Company first reported a position in 10x Genomics in Q4 2021 and held it in 5 quarters.
WhitTier Trust Company's 10x Genomics position peaked at $11.8K in Q4 2022.
258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on WhitTier Trust Company's 13F filing for Q1 2023, filed 21 Apr 2023.